Diomed Holdings, Inc. to Present at C.E. Unterberg, Towbin Life Sciences Conference
20 Octubre 2006 - 6:15PM
Business Wire
Diomed Holdings, Inc. (AMEX:DIO), a leading developer and marketer
of minimally-invasive medical technologies, including its patented
EndoVenous Laser Treatment (EVLT�) for varicose veins, today
announced that James Wylie, President and CEO, will be presenting
an overview of the Company�s business at the upcoming C. E.
Unterberg, Towbin Life Sciences Conference at the Palace Hotel in
New York on Tuesday, October 31, 2006 at 1:00 p.m. EST. To take
part in this webcast presentation, please login at either
http://ir.diomedinc.com or http://www.wsw.com/webcast/ceut5/dio/.
About Diomed Diomed develops and commercializes minimal and
micro-invasive medical procedures that use its proprietary laser
technologies and disposable products. Diomed�s EVLT� laser vein
ablation procedure is used in varicose vein treatments. Diomed also
provides photodynamic therapy (PDT) for use in cancer treatments,
and dental and general surgical applications. The EVLT� procedure
and the Company�s related products were cleared by the United
States FDA in January of 2002. Along with lasers and single-use
procedure kits for its EVLT� laser vein treatment, the Company
provides its customers with state of the art physician training and
practice development support. Additional information is available
on the Company�s website: www.evlt.com. EVLT� is a registered
trademark of Diomed Inc., Andover, MA. Diomed Holdings, Inc.
(AMEX:DIO), a leading developer and marketer of minimally-invasive
medical technologies, including its patented EndoVenous Laser
Treatment (EVLT(R)) for varicose veins, today announced that James
Wylie, President and CEO, will be presenting an overview of the
Company's business at the upcoming C. E. Unterberg, Towbin Life
Sciences Conference at the Palace Hotel in New York on Tuesday,
October 31, 2006 at 1:00 p.m. EST. To take part in this webcast
presentation, please login at either http://ir.diomedinc.com or
http://www.wsw.com/webcast/ceut5/dio/. About Diomed Diomed develops
and commercializes minimal and micro-invasive medical procedures
that use its proprietary laser technologies and disposable
products. Diomed's EVLT(R) laser vein ablation procedure is used in
varicose vein treatments. Diomed also provides photodynamic therapy
(PDT) for use in cancer treatments, and dental and general surgical
applications. The EVLT(R) procedure and the Company's related
products were cleared by the United States FDA in January of 2002.
Along with lasers and single-use procedure kits for its EVLT(R)
laser vein treatment, the Company provides its customers with state
of the art physician training and practice development support.
Additional information is available on the Company's website:
www.evlt.com. EVLT(R) is a registered trademark of Diomed Inc.,
Andover, MA.
Diomed (AMEX:DIO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Diomed (AMEX:DIO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Diomed Holdings, (American Stock Exchange): 0 recent articles
Más de Diomed Holdings, Inc. ArtÃculos de Noticias